Cargando…

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies

SIMPLE SUMMARY: The Epstein–Barr virus, also termed human herpes virus 4, is a human pathogenic double-stranded DNA virus. It is highly prevalent and has been linked to the development of 1–2% of cancers worldwide. EBV-associated malignancies encompass various structural and epigenetic alterations....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Marcus, Jasinski-Bergner, Simon, Mandelboim, Ofer, Wickenhauser, Claudia, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533749/ https://www.ncbi.nlm.nih.gov/pubmed/34680337 http://dx.doi.org/10.3390/cancers13205189

Ejemplares similares

Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma
por: Jasinski-Bergner, Simon, et al.
Publicado: (2021)

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2016)

Molecular mechanisms of human herpes viruses inferring with host immune surveillance
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2018)

Role of HLA-G in Viral Infections
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma
por: Fänder, Johannes, et al.
Publicado: (2019)

The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition
por: Chaouat, Abigael Eva, et al.
Publicado: (2021)

Immune Therapy Resistance and Immune Escape of Tumors
por: Seliger, Barbara, et al.
Publicado: (2021)

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection
por: Seliger, Barbara, et al.
Publicado: (2022)

Reshaping tumor immune microenvironment by Epstein-Barr virus activation in the stroma of colorectal cancer
por: Park, Hyun Ju, et al.
Publicado: (2022)

Epstein-Barr virus as a promoter of tumorigenesis in the tumor microenvironment of breast cancer (Review)
por: Gómez-Archila, José Damián, et al.
Publicado: (2023)

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
por: Hutcheson, Rebecca L., et al.
Publicado: (2021)

Immune Escape by Non-coding RNAs of the Epstein Barr Virus
por: Münz, Christian
Publicado: (2021)

Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
por: George, Jason T, et al.
Publicado: (2023)

An update: Epstein-Barr virus and immune evasion via microRNA regulation
por: Zuo, Lielian, et al.
Publicado: (2017)

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options
por: Wass, Maxi, et al.
Publicado: (2018)

Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
por: Seliger, Barbara, et al.
Publicado: (2020)

Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma
por: Wickenhauser, Claudia, et al.
Publicado: (2021)

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018)

CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2020)

HLA-G-specific microRNAs a novel approach for targeting tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2013)

Epstein barr virus encodes miRNAs to assist host immune escape
por: Li, Weiming, et al.
Publicado: (2020)

Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy
por: Kryst, Piotr, et al.
Publicado: (2020)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis
por: Jasinski-Bergner, Simon, et al.
Publicado: (2020)

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
por: Voisset, Cécile, et al.
Publicado: (2014)

Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta
por: Almohammed, Rajaei, et al.
Publicado: (2018)

Differentiated tumor immune microenvironment of Epstein–Barr virus-associated and negative gastric cancer: implication in prognosis and immunotherapy
por: Ma, Jing, et al.
Publicado: (2017)

Detection of Epstein–Barr virus infection in thymic epithelial tumors by nested PCR and Epstein–Barr-encoded RNA ISH
por: Zhao, Li, et al.
Publicado: (2023)

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
por: Vito, Alyssa, et al.
Publicado: (2020)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma
por: Schäfer, Helene, et al.
Publicado: (2023)

Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
por: Seliger, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bt9tr9k0k60rej9gteclte7uc4